共 203 条
[1]
Stewart WF(2003)Prevalence and burden of overactive bladder in the United States World J Urol 20 327-336
[2]
Van Rooyen JB(2005)Methods for assessing drug-related anticholinergic activity Pharmacotherapy 25 1592-1601
[3]
Cundiff GW(2008)Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes J Am Geriatr Soc 56 847-853
[4]
Rudd KM(2001)Anticholinergic effects of medication in elderly patients J Clin Psychiatry 62 11-14
[5]
Raehl CL(2008)Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan J Manag Care Pharm 14 291-301
[6]
Bond CA(2005)Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California medicaid program Value Health 8 495-505
[7]
Abbruscato TJ(2006)Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder Br J Pharmacol 148 565-578
[8]
Stenhouse AC(2005)Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients J Am Geriatr Soc 53 2195-2201
[9]
Sink KM(2006)Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects Eur Urol 50 317-326
[10]
Thomas J(2007)Cumulative incidence of chronic constipation: a population-based study 1988–2003 Aliment Pharmacol Ther 26 1521-1528